Skip to main content
Toggle navigation
Login
Home
Session Icons
Special Event
Livestream / Recorded
Multiple Session Occurences
Audience Response System
Ticketed Session
Presentado en Espanol
Closed Captioning
Scientific Program
Sold Out Ticketed Session
New & Evolving Topics
Traduccion Espanol
Rx (Pharmacology)
Poster Icons
Oral Presentations
Poster Presentations
Back
Favorite
Laura A. Knecht, MD
R&D / DCV Development
Sanofi
Abstract(s):
P4.A014: Teplizumab in children with newly diagnosed type 1 diabetes (T1D): outcomes from the Phase 3 PROTECT study
Monday, September 30, 2024
12:00 PM – 1:00 PM
EDT